Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2004;35:1709-1714
Published online before print May 20, 2004, doi: 10.1161/01.STR.0000131479.08005.ca
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
35/7/1709    most recent
01.STR.0000131479.08005.cav1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsang, S.-Y.
Right arrow Articles by Huang, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsang, S.-Y.
Right arrow Articles by Huang, Y.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Animal models of human disease
Right arrow Other Vascular biology

(Stroke. 2004;35:1709.)
© 2004 American Heart Association, Inc.


Original Contributions

Raloxifene Relaxes Rat Cerebral Arteries In Vitro and Inhibits L-Type Voltage-Sensitive Ca2+ Channels

Suk-Ying Tsang, PhD; Xiaoqiang Yao, PhD; Kirill Essin, BSc; Chi-Ming Wong, BSc; Franky L. Chan, PhD; Maik Gollasch, MD, PhD Yu Huang, PhD

From Department of Physiology (S.-Y.T., X.Y., C.M.W., Y.H.), Chinese University of Hong Kong, China; Department of Anatomy (F.L.C.), Chinese University of Hong Kong, China; Franz Volhard Clinic (K.E., M.G.), Berlin, Germany; and Department of Physiology (K.E., M.G.), Louisiana State University Health Sciences Center, New Orleans, La.

Correspondence to Dr Yu Huang, Department of Physiology, Faculty of Medicine, Chinese University of Hong Kong, Shatin, NT, Hong Kong, China. E-mail yu-huang{at}cuhk.edu.hk

Background and Purpose— Because of their mixed estrogen-agonist and estrogen-antagonist properties, selective estrogen receptor modulators (SERMs) are considered promising substitutes for hormone replacement therapy. Raloxifene and other SERMs confer estrogen-like cardiovascular protective effects but lack the carcinogenic activity of exogenous estrogen. However, little is known about the cerebrovascular action of raloxifene. Therefore, we studied the effects of raloxifene on the mechanisms regulating rat cerebral artery tone.

Methods and Results— Ring segments of the isolated rat posterior communicating cerebral arteries were mounted in a microvessel myograph for measurement of isometric tension. Whole-cell L-type voltage-sensitive Ca2+ currents were recorded using the perforated patch-clamp technique. Raloxifene (0.1 to 10 µmol/L) reduced the contractile responses to U46619, phenylephrine, and endothelin-1 in normal Krebs solution or to CaCl2 in Ca2+-free, high K+-containing solution. Raloxifene-induced relaxation was identical in endothelium-intact and endothelium-denuded rings. ICI 182780 had no effect on raloxifene-induced relaxation. Raloxifene reduced L-type Ca2+ currents with a pD2 of 5.98±0.06, close to that (6.44±0.09) for raloxifene-induced relaxation of 60 mmol/L K+-contracted rings.

Conclusions— This study demonstrates that raloxifene acutely relaxes rat cerebral arteries largely via an endothelium-independent mechanism, involving inhibition of Ca2+ influx through L-type Ca2+ channels.


Key Words: vasodilation • cerebrovascular circulation • rats




This article has been cited by other articles:


Home page
ICVTSHome page
E. Murakami, H. Iwata, M. Imaizumi, and H. Takemura
Prevention of arterial graft spasm by botulinum toxin: an in-vitro experiment
Interactive CardioVascular and Thoracic Surgery, September 1, 2009; 9(3): 395 - 398.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
K. A. Bolanz, M. A. Hediger, and C. P. Landowski
The role of TRPV6 in breast carcinogenesis
Mol. Cancer Ther., February 1, 2008; 7(2): 271 - 279.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
C. Pinna, C. Bolego, P. Sanvito, V. Pelosi, R. Baetta, A. Corsini, R. M. Gaion, and A. Cignarella
Raloxifene Elicits Combined Rapid Vasorelaxation and Long-Term Anti-Inflammatory Actions in Rat Aorta
J. Pharmacol. Exp. Ther., December 1, 2006; 319(3): 1444 - 1451.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
D. N. Krause, S. P. Duckles, and D. A. Pelligrino
Influence of sex steroid hormones on cerebrovascular function
J Appl Physiol, October 1, 2006; 101(4): 1252 - 1261.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
F. P. Leung, X. Yao, C.-W. Lau, W.-H. Ko, L. Lu, and Y. Huang
Raloxifene relaxes rat intrarenal arteries by inhibiting Ca2+ influx
Am J Physiol Renal Physiol, July 1, 2005; 289(1): F137 - F144.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
Y.-C. Chan, F.-P. Leung, X. Yao, C.-W. Lau, P. M. Vanhoutte, and Y. Huang
Raloxifene Relaxes Rat Pulmonary Arteries and Veins: Roles of Gender, Endothelium, and Antagonism of Ca2+ Influx
J. Pharmacol. Exp. Ther., March 1, 2005; 312(3): 1266 - 1271.
[Abstract] [Full Text] [PDF]